Patent details

Basic Information

Publication number:

EP2683396

PCT Application Number:

PCT/EP/2012/054142

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP127076248

PCT Publication Number:

WO/2012/120124

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FACTOR XII INHIBITORS FOR THE TREATMENT OF SILENT BRAIN ISCHEMIA OR STROKE

French Title of Invention:

INHIBITEURS DU FACTEUR XII POUR TRAITER L'ISCHÉMIE CÉRÉBRALE SILENCIEUSE OU L'ACCIDENT VASCULO-CÉRÉBRAL

German Title of Invention:

FAKTOR XII-HEMMER ZUR BEHANDLUNG VON SCHLEICHENDER ISCHÄMIE ODER SCHLAGANFALL

SPC Number:

Dates

Filing date:

09/03/2012

Grant date:

14/09/2016

EP Publication Date:

14/09/2016

PCT Publication Date:

13/09/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

15/01/2014

EP B1 Publication Date:

14/09/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

09/03/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

09/03/2012

 

 

Name:

CSL Behring GmbH

Address:

Emil-von-Behring-Strasse 76, 35041 Marburg, Germany (DE)

Name:

The General Hospital Corporation

Address:

55 Fruit Street, Boston, MA 02114, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

28/09/2016

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

WEISSLEDER Ralph

Address:

United States (US)

2

Name:

NOLTE Marc

Address:

Germany (DE)

3

Name:

DICKNEITE Gerhard

Address:

Germany (DE)

4

Name:

NAHRENDORF Matthias

Address:

United States (US)

5

Name:

STOLL Guido

Address:

Germany (DE)

Priority

1

Priority Number:

201161457360

Priority Date:

09/03/2011

Priority Country:

United States (US)

2

Priority Number:

11157555

Priority Date:

09/03/2011

Priority Country:

European Patent Office (EPO) (EP)

3

Priority Number:

201161496746

Priority Date:

14/06/2011

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 38/55;

Annual Fees

Annual Fee Due Date:

31/03/2026

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

27/02/2025

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages